Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug
<p>Abstract</p> <p>Introduction</p> <p>Research is an essential tool in facing the challenges of scaling up interventions and improving access to services. As in many other countries, the translation of research evidence into drug policy action in Tanzania is often cons...
Main Authors: | Gonzalez-Block Miguel A, Mubyazi Godfrey M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-10-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/4/1/51 |
Similar Items
-
Comparative efficacy of chloroquine and pyrimethamine-sulfadoxine versus artemether and pyrimethamine-sulfadoxine in the treatment of uncomplicated falciparum malaria in children
by: Femmy Tambajong, et al.
Published: (2016-10-01) -
Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016–2017
by: Eric Rogier, et al.
Published: (2020-05-01) -
Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies
by: Felger Ingrid, et al.
Published: (2005-11-01) -
Chloroquine and Sulfadoxine–Pyrimethamine Resistance in Sub-Saharan Africa—A Review
by: Alexandra T. Roux, et al.
Published: (2021-06-01) -
Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum
by: Aleisha R. Brock, et al.
Published: (2017-05-01)